Glivec - New Hope For CMC Patients
For those unlucky to be afflicted by the deadly chronic myeloid leukemia (CMC) and their near and dear ones, there's some good news. One of the deadliest forms of leukemia - commonly called 'blood cancer' - kills thousands across the globe. Chronic myeloid leukemia was one of the deadliest killers around and still continues to be one. But there's good news. Multinational pharmaceutical gia...Novartis is the world's sixth-largest drugmaker (by sales). ..Novartis was formed after merger of two Swiss companies, Sandoz Ltd. and Ciba-Geigy."Novartis ..is emerging as one of the premier powerhouses in the global pharmaceuticals industry," ..says Richard R. Stover, senior analyst with brokerage Natexis Bleichroeder Inc. ..in New York. The new cancer drug, Glivec's success led to Novartis re...Glivec, a drug used to treat chronic myeloid leukemia has shown to improve the survival rates in 90 percent of patients with the cancer.// The National Institute for health and Clinical Excellence (NICE), which regulates drug approvals in the UK had only wanted to approve Glivec for advanced cases, but the drug has not proved itself in clinical trials. ....CML is a common form of blood cancer, w...